Home » Topics » Regulatory » Patents

Patents
RSS

T2YC presents new integrin modulators

Feb. 21, 2022

Guangzhou Henovcom Bioscience discloses new antivirals

Feb. 21, 2022

Shaanxi Synthetic Pharmaceutical divulges new antiarthritic drugs

Feb. 21, 2022

BioWorld MedTech Patent Highlights: Week 6

From Current Patent Gazette

Feb. 18, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

New HSD17B13 inhibitors identified at Inipharm

Feb. 18, 2022

Fog Pharmaceuticals describes stapled peptides targeting beta-catenin

Feb. 18, 2022

New SREBP inhibitors identified at Capulus Therapeutics

Feb. 18, 2022

Merck & Co. presents new adenosine A2A and/or A2B receptor antagonists

Feb. 18, 2022

New coagulation factor XIa inhibitors synthesized at Janssen Pharmaceutica

Feb. 18, 2022

Angion Biomedica divulges new ROCK1/ROCK2 inhibitors

Feb. 17, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...